Frederick Millard, MD
Add to Favorites
Physicians & Surgeons, Physicians & Surgeons, Hematology (Blood), Physicians & Surgeons, Oncology
200 W Arbor Dr, San Diego, CA 92103
858-657-7876
CLOSED NOW:
Today: Closed
PHOTOS AND VIDEOS
Sponsored Links
Alvarado Physicians Medical Group CALIFORNIA
6699 Alvarado Rd, San Diego, CA 92120
Gaslamp Medical Center
250 Market St, San Diego, CA 92101
REVIEWS Write a Review
- General Info
- Dr. Millard is co-director of the genitourinary oncology team at UC San Diego Moores Cancer Center. He works in close collaboration with the Urology Department in caring for patients with urological cancers, including prostate cancer, bladder cancer, testicular cancer and other germ cell tumors, and kidney cancer, as well as other rarer cancer types. He leads the clinical research effort conducting clinical trials for patients with these illnesses. His team is the only oncology program dedicated solely to urological cancers in the San Diego area. He has a special clinical interest in testicular cancer/germ cell tumors and the considerations surrounding treatment of cancer in adolescents and young adults.UC San Diego Health LinksFor more information on cancer treatment at UC San Diego Health, see https://health.ucsd.edu/specialties/cancer/Pages/default.aspx. For more information on the treatment of urologic cancers at UC San Diego Health, see https://health.ucsd.edu/specialties/cancer/programs/urologic/Pages/default.aspx.
- Extra Phones
Phone: 858-822-6100
- Hours
- Regular Hours
Mon - Fri: Sat - Sun Closed - Categories
- Physicians & Surgeons, Physicians & Surgeons, Hematology (Blood), Physicians & Surgeons, Oncology
- Brands
- UC San Diego Health
- Location
- UC San Diego Health
- Other Links
https://providers.ucsd.edu/details/11449/medical-oncology-cancer
https://health.ucsd.edu/Request_appt/Pages/default.aspx?fname=Frederick&lname=Millard
Sponsored Links
Skin Surgery Medical Group Inc.
5222 Balboa Ave Fl 6, San Diego, CA 92117
Data provided by one or more of the following: Thryv, Data Axle, Yext.